Showing results (1-10 of 1,029) with videos related to
Sort By:
Pageof 103
British Journal of Rheumatology|October 1, 1993
Irreversible blindness in systemic lupus erythematosisS M Nasser, P Fields, D Calver, et al.Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|July 5, 2001
The prospect of treating rheumatoid arthritis with recombinant human interleukin-1 receptor antagonistB BresnihanSeminars in Arthritis and Rheumatism|May 18, 2001
The safety and efficacy of interleukin-1 receptor antagonist in the treatment of rheumatoid arthritisB BresnihanThe Journal of Rheumatology|March 25, 1999
Pathogenesis of joint damage in rheumatoid arthritisB BresnihanThe Journal of Rheumatology. Supplement|June 21, 2001
Treating early rheumatoid arthritis in the younger patientB BresnihanClinical and Experimental Rheumatology|March 3, 2004
Anakinra as a new therapeutic option in rheumatoid arthritis: clinical results and perspectivesB BresnihanRheumatology (Oxford, England)|June 21, 2003
Clinical and radiological effects of anakinra in patients with rheumatoid arthritisB Bresnihan, M CobbyIrish Journal of Medical Science|July 1, 1991
Experience with a juvenile rheumatology clinicG Yanni, B BresnihanBailliere'S Clinical Rheumatology|February 1, 1993
Systemic lupus erythematosusD Mulherin, B BresnihanRheumatic Diseases Clinics of North America|August 26, 1998
Interleukin-1 receptor antagonistB Bresnihan, G CunnanePageof 103